U.S. Markets closed
  • S&P 500

    3,821.35
    -20.59 (-0.54%)
     
  • Dow 30

    31,802.44
    +306.14 (+0.97%)
     
  • Nasdaq

    12,609.16
    -310.99 (-2.41%)
     
  • Russell 2000

    2,202.98
    +10.77 (+0.49%)
     
  • Crude Oil

    64.81
    -0.24 (-0.37%)
     
  • Gold

    1,679.60
    +1.60 (+0.10%)
     
  • Silver

    25.22
    -0.05 (-0.21%)
     
  • EUR/USD

    1.1857
    -0.0068 (-0.5691%)
     
  • 10-Yr Bond

    1.5960
    +0.0420 (+2.70%)
     
  • Vix

    25.47
    +0.81 (+3.28%)
     
  • GBP/USD

    1.3818
    -0.0010 (-0.0746%)
     
  • USD/JPY

    108.9440
    +0.5620 (+0.5185%)
     
  • BTC-USD

    50,947.24
    +92.13 (+0.18%)
     
  • CMC Crypto 200

    1,045.17
    +20.96 (+2.05%)
     
  • FTSE 100

    6,719.13
    +88.61 (+1.34%)
     
  • Nikkei 225

    28,743.25
    -121.07 (-0.42%)
     

Enanta Pharmaceuticals: Fiscal 1Q Earnings Snapshot

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

WATERTOWN, Mass. (AP) _ Enanta Pharmaceuticals Inc. (ENTA) on Monday reported a fiscal first-quarter loss of $8.3 million, after reporting a profit in the same period a year earlier.

The Watertown, Massachusetts-based company said it had a loss of 41 cents per share.

The results beat Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 82 cents per share.

The biotechnology company posted revenue of $31.7 million in the period, also surpassing Street forecasts. Four analysts surveyed by Zacks expected $26.6 million.

Enanta Pharmaceuticals shares have increased 31% since the beginning of the year. In the final minutes of trading on Monday, shares hit $54.95, a fall of 1% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ENTA at https://www.zacks.com/ap/ENTA